Sex modifies APOE epsilon 4 dose effect on brain tau deposition in cognitively impaired individuals

Shaozhen Yan,Chaojie Zheng,Manish D Paranjpe,Yanxiao Li,Weihua Li,Xiuying Wang,Tammie L S Benzinger,Jie Lu,Yun Zhou
DOI: https://doi.org/10.1093/brain/awab160
IF: 14.5
2021-01-01
Brain
Abstract:Recent studies in cognitively unimpaired elderly individuals suggest that the APOE epsilon 4 allele exerts a dosage-dependent effect on brain tau deposition. The aim of this study was to investigate sex differences in APOE epsilon 4 gene dosage effects on brain tau deposition in cognitively impaired individuals using quantitative F-18-flortaucipir PET. Preprocessed F-18-flortaucipir tau PET images, T-1-weighted structural MRI, demographic information, global cortical amyloid-beta burden measured by F-18-florbetapir PET, CSF total tau and phosphorylated tau measurements were obtained from the Alzheimer's Disease Neuroimaging Initiative database. Two hundred and sixty-eight cognitively impaired individuals with 146 APOE epsilon 4 non-carriers and 122 carriers (85 heterozygotes and 37 homozygotes) were included in the study. An iterative reblurred Van Cittert iteration partial volume correction method was applied to all downloaded PET images. Magnetic resonance images were used for PET spatial normalization. Twelve regional standardized uptake value ratios relative to the cerebellum were computed in standard space. APOE epsilon 4 dosage x sex interaction effect on F-18-flortaucipir standardized uptake value ratios was assessed using generalized linear models and sex-stratified analysis. We observed a significant APOE epsilon 4 dosage x sex interaction effect on tau deposition in the lateral temporal, posterior cingulate, medial temporal, inferior temporal, entorhinal cortex, amygdala, parahippocampal gyms regions after adjusting for age and education level (P < 0.05). The medial temporal, entorhinal cortex, amygdala and parahippocampal gyms regions retained a significant APOE epsilon 4 dosage x sex interaction effect on tau deposition after adjusting for global cortical amyloid-8 (P < 0.05). In sex-stratified analysis, there was no significant difference in tau deposition between female homozygotes and heterozygotes (P > 0.05). In contrast, male homozygotes standardized uptake value ratios were significantly greater than heterozygotes or non-carriers throughout all 12 regions of interest (P < 0.05). Female heterozygotes exhibited significantly increased tau deposition compared to male heterozygotes in the orbitofrontal, posterior cingulate, lateral temporal, inferior temporal, entorhinal cortex, amygdala and parahippocampal gyms (P < 0.05). Results from voxel-wise analysis were similar to the ones obtained from regions of interest analysis. Our findings indicate that an APOE epsilon 4 dosage effect on brain region-specific tau deposition exists in males, but not females. These results have important clinical implications towards developing sex and genotype-guided therapeutics in Alzheimer's disease and uncovers a potential explanation underlying differential APOE epsilon 4-associated Alzheimer's risk in males and females.
What problem does this paper attempt to address?